DEA warns of deadly drug mix fueling national crisis
December 07, 2024 | Veterinary Medical Board, Boards and Commissions, Executive, California
This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »
On December 7, 2024, the Veterinary Medical Board of California held a webinar focused on the critical issue of drug diversion in veterinary practices. The meeting highlighted the growing concern over the misuse of controlled substances and the need for effective prevention strategies.
Drug diversion refers to the illegal use of medications that are meant for legitimate medical purposes. This issue is particularly prevalent in healthcare settings, including veterinary practices, where access to controlled substances is easier. The board discussed the importance of identifying patterns of losses in medications and understanding the potential for diversion.
The webinar presented a list of commonly diverted medications, emphasizing opioids as the most frequently misused drugs. Other substances of concern included stimulants, benzodiazepines, and certain sedatives. The board referenced the latest DEA National Drug Threat Report, which identified amphetamines, pain relievers, and sedatives as the top misused prescription medications.
A significant focus was placed on specific drugs trending in illicit use within veterinary medicine. Ketamine, a controlled substance used as an anesthetic, has seen increased diversion. The board noted its popularity in party scenes and its street names, such as \"Special K.\"
Another drug discussed was Xylazine, a powerful sedative approved only for veterinary use. Although not federally controlled, its illicit use has surged, especially when mixed with fentanyl, leading to dangerous outcomes. The board warned that naloxone, typically used to reverse opioid overdoses, is ineffective against Xylazine.
The meeting also touched on other substances like metomidine and gabapentin, which have been linked to rising fatalities. Gabapentin, in particular, has shown a troubling increase in misuse, especially when combined with opioids.
The Veterinary Medical Board urged veterinarians to treat these drugs with the same caution as controlled substances. They recommended implementing tracking logs and secure storage practices to prevent theft and misuse.
Overall, the webinar underscored the urgent need for vigilance in veterinary practices to combat drug diversion and protect public health.
Drug diversion refers to the illegal use of medications that are meant for legitimate medical purposes. This issue is particularly prevalent in healthcare settings, including veterinary practices, where access to controlled substances is easier. The board discussed the importance of identifying patterns of losses in medications and understanding the potential for diversion.
The webinar presented a list of commonly diverted medications, emphasizing opioids as the most frequently misused drugs. Other substances of concern included stimulants, benzodiazepines, and certain sedatives. The board referenced the latest DEA National Drug Threat Report, which identified amphetamines, pain relievers, and sedatives as the top misused prescription medications.
A significant focus was placed on specific drugs trending in illicit use within veterinary medicine. Ketamine, a controlled substance used as an anesthetic, has seen increased diversion. The board noted its popularity in party scenes and its street names, such as \"Special K.\"
Another drug discussed was Xylazine, a powerful sedative approved only for veterinary use. Although not federally controlled, its illicit use has surged, especially when mixed with fentanyl, leading to dangerous outcomes. The board warned that naloxone, typically used to reverse opioid overdoses, is ineffective against Xylazine.
The meeting also touched on other substances like metomidine and gabapentin, which have been linked to rising fatalities. Gabapentin, in particular, has shown a troubling increase in misuse, especially when combined with opioids.
The Veterinary Medical Board urged veterinarians to treat these drugs with the same caution as controlled substances. They recommended implementing tracking logs and secure storage practices to prevent theft and misuse.
Overall, the webinar underscored the urgent need for vigilance in veterinary practices to combat drug diversion and protect public health.
View the Full Meeting & All Its Details
This article offers just a summary. Unlock complete video, transcripts, and insights as a Founder Member.
✓
Watch full, unedited meeting videos
✓
Search every word spoken in unlimited transcripts
✓
AI summaries & real-time alerts (all government levels)
✓
Permanent access to expanding government content
30-day money-back guarantee
